Innovating for three decades – How Snibe is committed to build a healthier world

2025 will mark the 30th anniversary of Snibe’s establishment. Since its founding, Snibe has adhered to the mission of quality is our life, which has enabled us to continuously launch advanced products that satisfy customers and reassure patients. We remain committed to providing better IVD solutions globally. In the more than ten years since Snibe entered the Indian market, we have also been persistently working toward building a healthier India.

Snibe solutions
As of now, Snibe has launched a variety of innovative laboratory solutions that significantly enhance the level of automation in testing, operational efficiency, reliability of test results, and cost-effectiveness.

MAGLUMI X: The MAGLUMI X Tech is a technology applied in the state-of-the-art MAGLUMI X series fully-auto CLIA analyzers currently. With its outstanding features, laboratories now have access to more reliable and accurate testing results than ever before. In 2025, Snibe will launch the brand new fastest MAGLUMI analyzer – the MAGLUMI X10, which provides an unbelievably high speed of 1000 T/h without increasing the footprint. And we are also excited to announce that the MAGLUMI test menu now has over 250 assays, covering most of common or rare disease tests.

SATLARS T8 and iXLab: The latest TLA Solutions – iXLab smart laboratory software and SATLARS T8 total laboratory system, are already being promoted in India. SATLARS T8 is a strong and powerful laboratory solution that offers high efficiency, great flexibility, and easy operation to explore more potential of laboratories. It can be integrated with iXLab to calculate the optimal solution for all laboratory tests under the support of multiple algorithms and models, intelligently judging the reliability of results. This system also incorporates an AI platform to assist doctors remotely in accessing and analyzing data. Through this comprehensive laboratory solution, doctors can not only save valuable time to focus on other important tasks, but also reduce the risk of exposure to infection in high-risk operations.

Biolumi CX10: It is an integrated system that combines the MAGLUMI X10 (1000 T/h) and the new biochemical analyzer Biossays C10 (3000 T/h) with the ISE unit. It integrates the advantages of X10 and C10 and also can be connected to the TLA system. The intelligent management system simplifies operational workflows, establishing a fully automated laboratory pipeline. With its exceptional throughput, CX10 is an ideal solution for laboratories to seek to optimize workflow efficiency and detection accuracy. In addition, C10 also has new features, such as a buffer reagent disk, auxiliary display system, and support for whole-blood detection (for HbA1c) function, which greatly simplifies the complex operation in the traditional laboratory, making CX10 achieve 1+1>2.

In 2025, and beyond, we will continue to launch more innovative products and solutions, integrating AI, ML, BDA, and cloud computing capabilities to provide comprehensive solutions and higher throughput analyzers for our clients. Our goal is to bring more healthcare opportunities to people around the world.

Snibe global strategies
Snibe’s market coverage is now growing continuously. Today, Snibe’s instruments are serving in over 156 countries and regions. We assist the localization process by establishing local offices and subsidiaries, and providing more comprehensive service support to local customers.

Snibe India, as the most successful team in localization, has created many equal job opportunities locally, and attracted a large pool of talent. With a rich talent reserve, we can offer better pre-sales and after-sales services to our clients, including a call center in India, to ensure the after-sales-support for our customers. Furthermore, we have established a complete product supply chain to meet urgent needs, and built a comprehensive supply service system by setting up local warehouses in multiple states and offices in major cities, such as Delhi, Mumbai, and Hyderabad.

We are also honored to establish partnerships with excellent distributors, renowned hospitals, and authoritative institutions. Together, we strive to create a better healthcare environment and provide better medical conditions for everyone.

The past and the future
As an initial step in Snibe’s global business expansion, Snibe India has established mature partnerships with numerous hospitals and laboratories across the country through extensive localization efforts over the past few years. In the future, we will also participate in various local research collaborations and academic initiatives. At the same time, we will develop products that better suit the Indian market through localized research, aiming to provide more reliable and accessible healthcare. Looking ahead, we will continue to focus on providing innovative and high-quality solutions to meet the evolving demands, contributing to building a healthier world.